192 related articles for article (PubMed ID: 17337205)
1. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
[TBL] [Abstract][Full Text] [Related]
2. International collaborative study for establishment of the 2nd WHO International Standard for Haemophilus influenzae type b polysaccharide.
Mawas F; Burkin K; Dougall T; Saydam M; Rigsby P; Bolgiano B;
Biologicals; 2015 Nov; 43(6):492-503. PubMed ID: 26298195
[TBL] [Abstract][Full Text] [Related]
3. Collaborative study on saccharide quantification of the
Rosskopf U; Daas A; Terao E; von Hunolstein C
Pharmeur Bio Sci Notes; 2017; 2017():44-68. PubMed ID: 29017702
[TBL] [Abstract][Full Text] [Related]
4. The determination of phosphorus in Haemophilus influenzae type b conjugate vaccines by inductively coupled plasma-atomic emission spectrometry.
Swartz LA; Progar JJ; May JC
Biologicals; 2000 Dec; 28(4):227-31. PubMed ID: 11237358
[TBL] [Abstract][Full Text] [Related]
5. HPAEC-PAD method for the analysis of alkaline hydrolyzates of Haemophilus influenzae type b capsular polysaccharide.
de Haan A; van der Put RM; Beurret M
Biomed Chromatogr; 2013 Sep; 27(9):1137-42. PubMed ID: 23681893
[TBL] [Abstract][Full Text] [Related]
6. [Validation of an ELISA assay for the quantification of antibodies against Haemophilus influenzae type b capsular polysaccharide].
Toraño Peraza G; Hernández Vadell I; Baly A; Toledo Romaní ME
Rev Cubana Med Trop; 2005; 57(3):185-91. PubMed ID: 17969271
[TBL] [Abstract][Full Text] [Related]
7. A simple and rapid method for measuring unconjugated capsular polysaccharide (PRP) of Haemophilus influenzae type b in PRP-tetanus toxoid conjugate vaccine.
Guo YY; Anderson R; McIver J; Gupta RK; Siber GR
Biologicals; 1998 Mar; 26(1):33-8. PubMed ID: 9637747
[TBL] [Abstract][Full Text] [Related]
8. Stability testing in Haemophilus influenzae type b conjugate vaccines.
Klug B
Dev Biol Stand; 1996; 87():263-7. PubMed ID: 8854026
[TBL] [Abstract][Full Text] [Related]
9. HPAEC-PAD quantification of Haemophilus influenzae type b polysaccharide in upstream and downstream samples.
van der Put RM; de Haan A; van den IJssel JG; Hamidi A; Beurret M
Vaccine; 2015 Nov; 33(48):6908-13. PubMed ID: 25045809
[TBL] [Abstract][Full Text] [Related]
10. A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae b-Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations.
Saydam M; Rigsby P; Mawas F
Biologicals; 2014 Jan; 42(1):29-33. PubMed ID: 24200313
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a candidate International Standard for Meningococcal Group C polysaccharide.
Vipond C; Mulloy B; Rigsby P; Burkin K; Bolgiano B;
Biologicals; 2012 Sep; 40(5):353-63. PubMed ID: 22622331
[TBL] [Abstract][Full Text] [Related]
12. An NMR spectroscopic identity test for the control of the capsular polysaccharide from Haemophilus influenzae type b.
Lemercinier X; Jones C
Biologicals; 2000 Sep; 28(3):175-83. PubMed ID: 10964444
[TBL] [Abstract][Full Text] [Related]
13. Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine.
Ferguson M; Heath A
Biologicals; 2004 Dec; 32(4):195-205. PubMed ID: 15572101
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
15. Relationships among physico-chemical and biological tests for a synthetic Hib-TT conjugate vaccine.
Cuervo ML; Pérez LR; Oviedo M; Costa L; Perdomo V
Vaccine; 2007 Jan; 25(1):194-200. PubMed ID: 17161239
[TBL] [Abstract][Full Text] [Related]
16. Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.
Ravi G; Venkatesh YP
Glycoconj J; 2014 Nov; 31(8):573-85. PubMed ID: 25108762
[TBL] [Abstract][Full Text] [Related]
17. Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB.
Xu Q; Klees J; Teyral J; Capen R; Huang M; Sturgess AW; Hennessey JP; Washabaugh M; Sitrin R; Abeygunawardana C
Anal Biochem; 2005 Feb; 337(2):235-45. PubMed ID: 15691503
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis A immunoglobulin: an international collaborative study to establish the second international standard.
Ferguson M; Sands D; Lelie N
Biologicals; 2000 Dec; 28(4):233-40. PubMed ID: 11237359
[TBL] [Abstract][Full Text] [Related]
19. High performance anion exchange chromatographic and colorimetric methods for quality assessment of total and free polysaccharide content in
Hussein AR; Rezk MR; Fathalla FAA; El-Saharty YS; Nadim AH
Anal Methods; 2022 Oct; 14(38):3757-3765. PubMed ID: 36106712
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae type b conjugate vaccine stability: catalytic depolymerization of PRP in the presence of aluminum hydroxide.
Sturgess AW; Rush K; Charbonneau RJ; Lee JI; West DJ; Sitrin RD; Hennessy JP
Vaccine; 1999 Mar; 17(9-10):1169-78. PubMed ID: 10195629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
